BIND Therapeutics is a biotechnology company incorporated in 2006; Pfizer acquired substantially all of its assets in 2016.
BIND’s product candidates were based on proprietary polymeric nanoparticles called ACCURINS®, which are engineered to target specific cells and tissues in the body at sites of disease. ACCURINS®, which continue to be developed with Pfizer, have the potential to achieve therapeutic outcomes not currently possible with conventional treatment modalities.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 325 Vassar Street, Cambridge,ma 02139,united States
- Phone
- (617)491-3400
- in****@****ics.com
- Industry
- Biotechnology
- Website
- http://www.bindtherapeutics.com
- HQ
- Cambridge, MA
Bind Therapeutics Questions
Bind Therapeutics's helpline number is (617)491-3400
Bind Therapeutics's website is http://www.bindtherapeutics.com
Bind Therapeutics's LinkedIn profile is https://www.linkedin.com/company/bind-therapeutics
Bind Therapeutics has
4 employees.
View email and phone details for 4
employees at Bind Therapeutics.
Bind Therapeutics's industry is
Biotechnology
Bind Therapeutics's top competitors are
Helicos Biosciences Corporation,
Ring Therapeutics,
Omega Therapeutics,
Tarveda Therapeutics,
Flexion Therapeutics,
Sana Biotechnology, Inc.,
C4 Therapeutics, Inc.,
Tessera Therapeutics,
Generate:biomedicines,
Seer.
Bind Therapeutics's support email address is info@bindtherapeutics.com
Bind Therapeutics's categories are Biotechnology
Bind Therapeutics's founding year is 2006
